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Abstract
Background: Preventive measures are essential to limit the spread of new viruses; their uptake is key to their success.
However, the vaccination uptake in pandemic outbreaks is often low. We aim to elicit how disease and vaccination
characteristics determine preferences of the general public for new pandemic vaccinations.
Methods: In an internet-based discrete choice experiment (DCE) a representative sample of 536 participants (49%
participation rate) from the Dutch population was asked for their preference for vaccination programs in hypothetical
communicable disease outbreaks. We used scenarios based on two disease characteristics (susceptibility to and severity of
the disease) and five vaccination program characteristics (effectiveness, safety, advice regarding vaccination, media
attention, and out-of-pocket costs). The DCE design was based on a literature review, expert interviews and focus group
discussions. A panel latent class logit model was used to estimate which trade-offs individuals were willing to make.
Results: All above mentioned characteristics proved to influence respondents’ preferences for vaccination. Preference
heterogeneity was substantial. Females who stated that they were never in favor of vaccination made different trade-offs
than males who stated that they were (possibly) willing to get vaccinated. As expected, respondents preferred and were
willing to pay more for more effective vaccines, especially if the outbreak was more serious (J6–J39 for a 10% more
effective vaccine). Changes in effectiveness, out-of-pocket costs and in the body that advises the vaccine all substantially
influenced the predicted uptake.
Conclusions: We conclude that various disease and vaccination program characteristics influence respondents’ preferences
for pandemic vaccination programs. Agencies responsible for preventive measures during pandemics can use the
knowledge that out-of-pocket costs and the way advice is given affect vaccination uptake to improve their plans for future
pandemic outbreaks. The preference heterogeneity shows that information regarding vaccination needs to be targeted
differently depending on gender and willingness to get vaccinated.
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Introduction
Worldwide viral infection outbreaks with, e.g. Influenza
A(H1N1), SARS and H5N1 avian influenza, have been of serious
impact in the past [1]. If a new outbreak would occur, the global
spread is likely to be very rapid due to increased travel and
urbanization [2]. Extrapolation of the 1918–1920 avian influenza
pandemic mortality rates indicates that 62 million people would be
killed if a similar pandemic would happen these days [3].
Preventive measures, such as social distancing measures or
vaccination programs, are very important in limiting the spread
of new viruses [4,5]. However, the lack of willingness to act
according to such measures in crisis situations has proven to be a
major issue in the European Union [6]. Consequently, it is
important to have insights into what motivates individual people to
decide for or against vaccination. If motivations are known, these
can be addressed in pandemic preparedness plans and vaccination
strategies to increase vaccination rates and thus reduce the spread
of viral outbreaks. Furthermore, insight in motivations can lead to
an accurate prediction of the uptake of vaccinations, which is
helpful when implementing vaccination programs.
Various studies have been conducted to explore reasons why
individual members of the general public accepted or declined
pandemic vaccinations, especially focusing on the Influenza
A(H1N1) pandemic of 2009 [6–8]. These studies showed that
participation in vaccination programs is based on weighing the
burden of the vaccination (e.g. risk of side effects), against its
potential benefits (e.g. reduce the risk of infection), in a given
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context (e.g. severity of first cases of the disease). Several European
countries reported that public perception factors, such as poor
confidence in the need for the vaccine and concerns about the
relatively new vaccine, may have contributed to the low
vaccination coverage rates during the Influenza A (H1N1)
pandemic of 2009 [9]. Despite the presence of studies investigating
reasons of members of the general public to get vaccinated or not,
quantitative studies that assess the relative importance of these
reasons are lacking. It is precisely this information that is needed to
make highly effective health care policy plans regarding pandemic
outbreaks and vaccinations.
The aim of this study is to investigate the preferences of the
general population for pandemic vaccinations quantitatively.
Additionally, we aim to calculate the expected uptake of base
case vaccination programs for certain hypothetical outbreaks. The
current study is conducted within the scope of the project Effective
Communication in Outbreak Management: development of an
evidence-based tool for Europe (E-com@eu, http://www.ecomeu.
info/). This project aims to develop an evidence-based behavioral
and communication strategy for health professionals and agencies
throughout Europe in case of major outbreaks, by integration of
social, behavioral, communication, and media sciences.
Methods
Ethics Statement
A declaration of no objection was received from the Medical
Ethics Committee of the Erasmus MC, University Medical Center
Rotterdam (MEC-2012-263) after they reviewed the study
protocol. The methodology of this study, a survey amongst
healthy volunteers of an internet panel, does not fall within the
scope of the Medical Research Involving Human Subjects Act (in
Dutch: WMO). Although the aim of the study is of medical nature,
participants are not being subjected to any treatment or behavioral
adjustments.
Discrete choice experiments
DCE methodology is a survey-based stated preference tech-
nique to quantitatively investigate individual preferences. DCEs
have been widely used in health care to examine stakeholder
preferences [10,11] and have been previously used to examine
preferences for non-emergency vaccination programs, such as
Human Papilloma Virus (HPV) vaccinations and seasonal
influenza vaccinations [12,13]. In DCEs, it is assumed that a
medical intervention, such as a vaccination program, can be
described by its characteristics (attributes; e.g. effectiveness of a
vaccine, safety of the vaccine, and costs of the vaccine). Those
characteristics are further specified by variants of that character-
istic (attribute levels; e.g. for effectiveness of a vaccine: 30%, 50%,
70% and 90% effective). A second assumption is that the
individual’s preference for a medical intervention is determined
by the levels of those attributes [14]. The relative importance of
attributes can be assessed by presenting respondents a series of
questions in which they are asked to choose a preferred alternative
from a set of two or more hypothetical intervention alternatives
with varying combinations of attribute levels [15]. DCEs are based
on Lancaster’s consumer theory [16] and random utility theory
(RUT) [17] which assume that an individual acts rationally and
always chooses the alternative with the highest level of utility. We
followed recent guidelines for good DCE practice [18,19].
Selection of attributes and attribute levels
Only a limited number of attributes and attribute levels can be
used in a DCE, since otherwise the precision and reliability of the
results will decrease. On the other hand, one also needs to include
all relevant attributes and attribute levels to avoid that respondents
make significant inferences on omitted attributes or levels [19,20].
To obtain insights into possible attributes and their levels to be
included in this DCE, we conducted a strategic literature search in
three databases (searching for literature related to DCEs and/or
vaccination preferences in PubMed, Embase and PsychINFO),
semi-structured expert interviews and a focus group study. For the
expert interviews, we have spoken to nine experts of different
relevant fields, e.g. infectious diseases, vaccinations, preventive
behavior and implementation of preventive measures. For the
focus group study, we conducted seven focus group discussions
with the general population from the Netherlands; targeting urban
populations (two groups); populations of more rural areas (two
groups); and ethnic minorities in the Netherlands (three groups).
Eligible participants were recruited by a research company and via
the network of a researcher of the department of Public Health of
the Erasmus MC, University Medical Center Rotterdam, using
purposive sampling to ensure a diverse sample. Participants were
informed that they would receive a financial incentive (40 euros)
for their contribution and to cover travel costs and they were
informed that the data would be analyzed anonymously. All
participants gave written informed consent prior to the discussions.
All focus groups were audio taped, transcribed verbatim and
anonymously. The transcripts were analyzed using thematic
analysis using NVivo Software (version 10, http://www.
qsrinternational.com). The focus group study approach was
included in the study protocol for which a declaration of no
objection was received from the Medical Ethics Committee of the
Erasmus MC, University Medical Center Rotterdam. We used a
topic list based on the literature search and on two theoretic
models, i.e. the Health Belief Model [21] and to a lesser extent the
Protection Motivation Theory [22], to structure the focus group
discussions on outbreaks of new diseases and preventive measures.
These models assume that people react to a perceived threat, by
performing some action. The level of threat depends on the
perceived susceptibility to a disease and the perceived severity of a
disease. People weigh this threat to perceived benefits (such as
effectiveness) and barriers (such as costs) of actions. The model
assumes that also other factors influence someone’s intention to
take some action, such as cues to action (e.g. media attention) and
variables (age, sex, peer pressure etc.). We used these models as a
base for the topic list because of their largely empirically tested
ability to explain and predict intention of and complying with
preventive medical care recommendations, including vaccinations
[7,23,24]. Additionally, during the focus group discussions,
participants were asked to write down and rank the most
important reasons for them to get vaccinated during future
pandemic outbreaks.
Using these results and through extensive discussion with E-
com@eu project members, we selected two disease specific
scenario variables and five vaccination program attributes and
their corresponding levels (Table 1). For each scenario (which is a
combination of the susceptibility to the disease and severity of the
disease), three alternatives were presented, namely (i) No
vaccination, (ii) Vaccination A, and (iii) Vaccination B, where
the latter two are represented by combinations of effectiveness,
safety, advice, media and out-of-pocket costs. We aimed at
selecting a sufficient wide range of attribute levels that are realistic
now and will remain so in the near future and levels that were
relevant to policy as well as plausible and understandable for the
respondents. Furthermore, for each continuous attribute we
selected at least three levels to be able to test for non-linear
relationships.
Acceptance of Pandemic Vaccinations
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Study design and questionnaire
If all combinations of attribute levels were to be presented in
choice sets, this would have led to 576 (21 * 31 * 42 * 61)
hypothetical vaccination alternatives for 12 (31 * 41) different
disease outbreaks (scenarios). As it is not feasible to present a single
individual with all these scenarios and alternatives (i.e. full factorial
design), a subset of scenarios and alternatives (i.e. fractional
factorial design) was generated [25]. Zero priors for all categorical
variables and best-guess priors for all linear variables were used to
generate an efficient design by maximizing D-efficiency (using
Ngene software, version 1.1.1, http://www.choice-metrics.com/).
With this design we were able to estimate all main effects and a
number of two-way and higher order interactions between
attributes. Presenting a single individual with a large amount of
choice sets is expected to result in a lower response rate and/or
lower response reliability [26]. To reduce the burden on
respondents, a blocked design was used [15], which resulted in
dividing the 48 choice sets of the efficient design into 3
questionnaire versions containing 16 choice sets each in which
we ensured sufficient variation in attribute levels by finding blocks
with near attribute level balance.
Each questionnaire started with the introduction of a hypothet-
ical scenario (Figure S1). To facilitate comprehension of the DCE
task, respondents were provided with detailed information about
the attributes and attribute levels as well as with a clearly explained
example of a choice task prior to preference elicitation. The main
part of each questionnaire comprised 16 choice sets. In each
choice set, respondents first received some additional information
about the disease (i.e., the two scenario variables). Choice sets
consisted of two unlabeled vaccination alternatives (vaccination A
and vaccination B) and one opt-out alterative (see Figure S2 for a
screenshot of a choice set). This opt-out was necessary since, as in
real life, respondents are not obliged to take a vaccination.
Respondents were asked to consider all three alternatives in a
Table 1. Scenario variables, vaccination program attributes and their levels included in the DCE survey.
Scenario variables Levels
Susceptibility to the disease1 5%
10%
20%
Severity of the disease2 5%
25%
50%
75%
Vaccination program attributes Levels
Effectiveness of vaccine 30%
50%
70%
90%
Safety of the vaccine3,4 Unknown, expected to be safe (reference level)
Unknown, no experience with similar vaccines yet
Advice regarding the vaccine3 Family and/or friends recommend vaccination (reference level)
Family and/or friends discourage vaccination
Your doctor recommends vaccination
Your doctor discourages vaccination
Dutch government & RIVM recommend vaccination
International organizations recommend vaccination
Media coverage about the vaccine3 Traditional media5 positive (reference level)
Traditional media5 negative
Social/interactive media6 positive
Social/interactive media6 negative
Out-of-pocket costs J0
J50
J100
Notes: Levels of the no vaccination option were defined as: not applicable (n.a.), no side effects, n.a., n.a., J0 respectively. The scenario variables were the same across all
alternatives in one choice set. Abbreviation used: RIVM=Dutch abbreviation of National Institute for Public Health and the Environment. (1) Defined as the proportion
of population infected with the new disease, i.e. having symptoms. (2) Defined as the proportion of infected population that suffered severe symptoms (death, life-
threatening events, hospitalization and severe or permanent handicap). (3) The attributes ‘safety of the vaccine’, ‘advice about the vaccine’ and ‘media coverage about
the vaccine’ entered the analysis as categorical variables. (4) Long term severe side effects (death, life-threatening events, hospitalization, severe or permanent
handicap, or side effects leading to birth defects to an unborn fetus). Before the start of the choice tasks, respondents were informed that on the short term,
vaccinations resulted in mild side effects only. (5) Traditional media were defined as: radio, newspapers and television. (6) Social/interactive media were defined as:
blogs, Twitter and social network websites.
doi:10.1371/journal.pone.0102505.t001
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choice set as realistic alternatives and to choose the option that
appealed most to them in the given situation.
Attributes needed to be described as clearly as possible in the
choice sets since previous research has shown that respondents
may have difficulties with interpreting probabilities [27] and that
framing effects can influence DCE results [28–30]. Therefore, we
included graphs to demonstrate percentages and rates, used
realistic presentation of attributes (e.g. integers when discussing
rates that included humans), and used cost as the last attribute.
Furthermore, experts in the field of risk communication advised us
on how to present the choice sets in this DCE. For example, we
were advised to use the same type of graphs to present risks across
both scenario variables and attributes. The last section of each
questionnaire included questions on socio-demographic data and
questions on previous experiences with vaccination. It also
contained questions assessing experienced difficulty of the
questionnaire (five-point scale). The questionnaire was presented
to respondents in Dutch.
In order to test the survey, we conducted a formal pen and
paper pilot with 29 respondents in the Netherlands. Additionally,
we conducted five think-a-loud interviews [31] to qualitatively test
for any problems in interpretation, for the understanding of the
questions and to indicate whether respondents were providing a
meaningful response. This resulted in minor changes to the layout
and phrasing of the questionnaire. There was no need to adapt the
selected combinations of scenarios or attribute levels of the DCE
design. Since there were some adaptations to the questionnaire,
data of these pre-tests were not included in the final analysis. The
questionnaire is available from the authors on request.
To check the convergent validity of the DCE, we asked
respondents to rank the five vaccination program attributes from
most important to least important. External validation was not
possible since we were using a hypothetical disease outbreak.
Data collection
A market research company (Flycatcher) was hired to admin-
ister the online questionnaire to a representative sample of the
general adult population of the Netherlands. Their online panel
comprises 16,000 members and is ISO certified (ISO-26363).
Recruitment of potential new members is done by digital media,
paper invitations, face-to-face meetings and via intermediates.
Assuming a participation rate of 50%, a random sub sample of
1,083 adult panel members (see sample size calculation below) was
emailed a link to the questionnaire to participate in the current
study. Quota sampling was used to ensure even distributions with
respect to age, gender, education and region. A further quota was
applied to each ‘questionnaire version’ to ensure comparable
numbers of respondents in each of the three blocks of the design.
Progress bars and error messages were incorporated to encourage
completion. After completing the questionnaire, respondents were
given the opportunity to comment on the questionnaire or topic at
hand by filling out the free text question. The questionnaire was
online for twelve days in June 2013, when the target number of
500 respondents was reached. All panel members gave informed
consent prior to participating in the study and received a small
incentive (J2.20, in the form of credits) for completion of the
questionnaire.
Sample size calculation
The mean sample size for DCE studies in health care published
between 2005 and 2008 was 259, with nearly 40% of the sample
sizes in the range of 100 to 300 respondents [32]. No adequate
statistical methods exist to determine sample sizes for DCEs.
Therefore, the rules of thumb as suggested by Orme [33] are
frequently used. These rules recommend sample sizes for DCEs to
be at least 300 respondents and suggest that also the number of
tasks and alternatives should be taken into account when
determining sample sizes. Based on this information, we aimed
to have at least 500 respondents completing the questionnaire.
Statistical analysis
To assess preference heterogeneity, we used a latent class model
to analyze the DCE data. A latent class model [34,35] can be used
to identify the existence and the number of segments or classes in
the population (i.e. identifying different utility (preference)
functions across unobserved subgroups). Class membership is
latent (i.e., unobserved) because each respondent belongs to each
class up to a modeled probability and not deterministically
assigned by the analyst a priori. The model is flexible in that the
probability that sampled respondents belong to a particular class
can be linked to covariates (e.g. age, gender), hence allowing for
some understanding as to the make-up of the various class
segments [34].
To account for the panel nature of the data, with each
respondent completing 16 choice tasks, we used a panel version of
the latent class model. In order to determine the number of classes,
we selected the model with the best fit. We tested a number of
different specifications for the utility function (e.g., categorical or
numerical attribute levels, linearity, two-way interactions between
all attributes and several attribute transformations, see Figure S3
for specifications of the functions) and selected the model with the
lowest Akaike Information Criterion (AIC).
The latent class model estimates parameters in a class
assignment model (which includes socio-demographic variables
and thereby expresses the likelihood of a certain individual
belonging to a certain class) and class-specific coefficients for each
attribute (or interaction of attributes and scenario variables) in the
utility function. For the class-specific coefficients and interactions,
the statistical significance of a coefficient (P-value#0.05) indicated
that, conditional on belonging to that class, respondents consid-
ered the attribute important when making stated choices. In terms
of the class assignment parameters, statistically significant param-
eter estimates indicate that the covariate can be used to distinguish
between the different classes. For example, if the covariate male
gender is negatively and significantly associated with a particular
class in the assignment model, then this is indicative that men are
less likely to belong to that particular class than women.
The sign of the coefficient reflects whether the attribute had a
positive or negative effect on utility. The value of each coefficient
represents the importance respondents assign to an attribute
(level). However, different attributes utilize different units of
measurement. For example the coefficient ‘effectiveness of the
vaccine’ represented the importance per 10% protection rate.
When looking at a vaccine that generates a 90% protection rate,
the coefficient needs to be multiplied 9 times (9 times coefficient of
‘effectiveness of the vaccine’ of 10%=coefficient of ‘effectiveness
of the vaccine’ of 90%).
We calculated class specific importance scores (IS) to visualize
the relative importance of a given attribute in that class by dividing
the difference in utility between highest and lowest level for a
single attribute by the sum of the differences of all attributes for
that class, taking interaction effects into account [36]. An attribute
with an IS of 1 represents the most important attribute, while an
attribute with an IS of 5 represents the least important attribute.
Furthermore, we also calculated overall importance scores, by
taking class probability into account.
Acceptance of Pandemic Vaccinations
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Expected uptake of the vaccine
Choice probabilities (mean uptakes) were calculated to provide
a way to convey DCE results to policy makers that are more easily
understandable. We calculated the choice probability (i.e. the
mean uptake) for a base case vaccination for three given outbreaks
by taking the exponent of the total utility for vaccination divided
by the exponent of utility of both vaccination and no vaccination
taking the class probabilities into account. The base-case
vaccination program was chosen to resemble real life situations,
and included the following attribute levels: vaccine effectiveness
70%, supposed to be a safe vaccine, advised by friends and positive
traditional media attention, and no out-of-pocket costs. Outbreaks
were defined as mild, moderate and severe (respectively a
susceptibility and severity of 5% and 5%; 10% and 25%; and
20% 75%).
Trade-offs
We calculated willingness-to-pay (WTP) values for the effec-
tiveness of the vaccine attribute for mild, moderate and severe
outbreaks (respectively a susceptibility and severity of 5% and 5%;
10% and 25%; and 20% and 75%). A WTP value represents how
much one is willing to pay for a one unit change in the attribute of
interest, and is calculated by taking the ratio of the derivative of
the effectiveness attribute and the derivative of out-of-pocket costs.
Since effectiveness was included as both a main effect and as part
of an interaction effect with susceptibility to the disease and
severity of the disease, it is necessary to calculate the derivatives
with respect to all parts of the utility function where the attribute
appears [37]. Because a latent class model was used, overall WTP
measures can be calculated by weighing the conditional WTP
values by the probability that respondents belong to a given class.
We computed the confidence intervals using the Krinsky and
Robb procedure [38] (Figure S3).
We used NLogit 4.0 software (www.limdep.com) to estimate the
latent class models and SPSS 21.0 software (http://www-01.ibm.
com/software/analytics/spss/) for all other analysis.
Results
Respondents
The participation rate was 677/1083 (63%, Figure 1), which
reflected the expected response rate for this online panel. Of the
677 respondents, 548 completed the questionnaire. Respondents
who completed the questionnaire did not differ regarding sex
(p = 0.11) or educational level (p = 0.11) compared to respondents
who did not complete the questionnaire. However, respondents
who completed the questionnaire were younger (median age 50 vs.
53, p,0.01). Twelve respondents were excluded from the analysis,
because they completed the questionnaire too quick; they
completed the whole questionnaire in less than five minutes. Data
of 536 (49%) respondents were included in the analysis.
Respondents had a median age of 50 years (interquartile range
(IQR): 35–64), with a minimum of 18 and a maximum age of 89
years old (Table 2). 30% had a high educational level and 22% of
the respondents indicated that they had a positive attitude
regarding vaccination, i.e. that they would always get vaccinated.
Figure 1. Overview of respondents accessing the study.
doi:10.1371/journal.pone.0102505.g001
Acceptance of Pandemic Vaccinations
PLOS ONE | www.plosone.org 5 July 2014 | Volume 9 | Issue 7 | e102505
The sample was representative for the Dutch population regarding
age, gender, educational level and region.
The median completion time of the whole questionnaire was
13 minutes (median, IQR: 9.6–19). It took respondents a median
of 6.3 minutes (IQR: 4.2–9.6) to complete 16 choice tasks. The
time respondents needed to fill in one choice task decreased from a
median of 39 seconds (IQR: 20–62) for choice task 1 to 15 seconds
(IQR: 10–24) for choice task 16. 67% of the respondents marked
the number of choice tasks as ‘exactly the good number’ and 76%
marked the questions as clear or very clear. A minority (13%) of
the respondents found the questions hard or very hard to answer.
Most of the respondents found the topic interesting or very
interesting (87%). Responses to the free text question indicated
that respondents felt that they were adequately informed to answer
the questions in the questionnaire.
Table 2. Characteristics of respondents who completed the DCE survey (N = 536).
Characteristics Subcategory Sample statistics CBS statistics
Median IQR
Age in years 50 35–64
n % %
Age groups 18–24 years 49 9.2 11
25–34 years 78 15 16
35–44 years 84 16 19
45–54 years 107 20 19
55–64 years 92 17 16
.65 years 126 24 19
Gender Male 289 54 49
Country of birth Netherlands 517 96 -
Educational level Low 184 34 34
Average 192 36 40
High 160 30 26
Civil status Married 296 55 -
Registered partnership 48 9.0 -
Unmarried 133 25 -
Divorced 38 7.1 -
Widow/widower 21 3.9 -
Children Yes 345 64 -
Income in euros per year Minimal (,11.000) 37 6.9 -
Less than modal (11.000–23.000) 69 13 -
Modal (23.000–34.000) 127 24 -
1–2 times modal (34.000–56.000) 103 19 -
2 times modal or more (.56.000) 78 15 -
Do not know/do not want to say 122 23 -
Religion Yes 244 46 -
Perception of health Lower health than average 41 7.6 -
Medium health 195 36 -
Better health than average 300 56 -
Attitude regarding vaccination Always get vaccinated 120 22 -
Only if benefits . harms 259 48 -
Only if benefits . harms, but I do not think
this is the case in the real world
116 22 -
Never get vaccinated, even if
benefits . harms
41 7.6 -
Belongs to target group for seasonal flu vaccine Yes 239 45 -
No 270 45 -
No, but receives flu vaccination via work 27 5.0 -
Belongs to the target group and received seasonal flu
vaccination last year
Yes 160 60 -
Note: Abbreviations used: CBS = Statistics Netherlands, IQR = Interquartile range.
doi:10.1371/journal.pone.0102505.t002
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Direct ranking showed that respondents considered effectiveness
the most important vaccine specific attribute, followed by safety of
the vaccine and advice regarding the vaccine (Figure 2a–2c).
Respondents marked their doctors’ advice as most important,
followed by the advice of international organizations and the
advice of the Dutch government & National Institute of Public
Health and the Environment (Dutch abbreviation: RIVM).
Traditional media influenced the decision regarding vaccination
more than social media.
Discrete choice experiment results
The ‘no vaccination’ option was chosen in 37% of the choice
sets. 61 respondents (11.0%) always chose the ‘no vaccination’
Figure 2. a. Direct ranking of attributes. Note: The percentages represent the proportion of people that ranked that vaccination program
attribute as most important when deciding on vaccination. b. Direct ranking of attribute levels. Note: The percentages represent the proportion
of people that ranked that vaccination program attribute level of advice regarding the vaccination as most important when deciding on vaccination.
c. Direct ranking of attributes levels. Note: The percentages represent the proportion of people that ranked that vaccination program attribute
level of media coverage about the vaccination as most important when deciding on vaccination.
doi:10.1371/journal.pone.0102505.g002
Acceptance of Pandemic Vaccinations
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option. 113 respondents (21%) never chose the ‘no vaccination’
option.
Using a latent class model, two classes were identified (Table 3).
The average class probabilities within the sample were 0.63 for
class 1 and 0.37 for class 2. The probability to belong to a specific
class was dependent on two socio-demographic variables: the sex
of the respondent and the attitude of the respondent regarding
vaccination. Males and individuals who stated that they (possibly)
wanted to get vaccinated had the highest chance to belong to
latent class 1, while females and individuals who stated that they
would never get vaccinated had the highest chance to belong to
latent class 2. Other socio-demographic variables were not
significantly explaining class assignment probabilities.
The sign of the coefficient indicates whether the attribute had a
positive or negative effect on utility (Table 3). For example, the
positive sign for effectiveness and for side effects unknown, but
expected to be safe indicated that an effective and safe vaccination
was preferred over a vaccination which was less effective and with
which there was no experience yet. The negative sign for out-of-
pocket costs of vaccination indicated that respondents preferred
vaccinations with lower out-of-pocket costs. The positive sign of
the constant indicates that, everything else being equal, respon-
dents preferred no vaccination over vaccination.
Nearly all of the vaccine specific characteristics were statistically
significant (Table 3), proving to influence respondents’ preference
for vaccination. The interactions between the disease specific
characteristics and effectiveness were significant and positive. This
indicates that the preference for the level of effectiveness of a
vaccination is dependent upon the levels of severity and
susceptibility. If the susceptibility to or severity of a disease are
higher, while the effectiveness of a vaccination is the same,
preference for vaccination increases relative to no vaccination. In
other words, if the susceptibility to the disease or the severity of a
disease is higher, lower vaccination effectiveness will result in the
same utility level. Note that the two disease characteristics cannot
be included as a main effect but only as interaction effects, since
they are scenario variables that are constant across all vaccine
alternatives. All other 2-way interactions were not statistically
significant.
When comparing the overall importance scores (Table 3) with
the direct ranking question (Figure 2a), effectiveness of the vaccine
was considered the most important attribute in both preference
elicitation methods, especially when an outbreak was more serious,
and media coverage of the vaccine as the least important attribute.
These results support the convergent validity of the results.
Preference heterogeneity was substantial; respondents belonging
to latent class 1 seemed to place more weight on the effectiveness
of the vaccine than respondents of latent class 2 (IS of 2 for class 1
compared to an IS of 5 for class 2, in case of a mild outbreak).
However, in case of a severe outbreak, effectiveness was the most
important attribute for both latent classes. Respondents belonging
to class 2 were more influenced by the media and more sensitive to
costs than respondents belonging to latent class 1 (respectively an
IS of 3 and 1 for class 2, and an IS of 5 and 3 for class 1, in case of
a mild outbreak of the disease). For respondents of both classes, the
advice regarding vaccination of others was important. Respon-
dents in class 1 were most influenced by the advice of the
government & RIVM and international organizations, while
respondents in latent class 2 were most influenced by the
recommendation or discouraging of their physician.
Trade-offs
Based on the expressed preferences, respondents were willing to
pay J6.0 (95% Confidence Interval: J3.7–J8.3) to receive a 10%
more effective vaccine in case of a mild pandemic outbreak
(Table 4). If a pandemic outbreak was more severe the willingness
to pay for a vaccine which was 10% more effective increased up to
J20 (J18–J22) in case of a moderate outbreak and J39 (J36–
J44) in case of a severe outbreak.
Expected uptake of the vaccine
The mean predicted uptake of the base-case vaccination
program increased from 50% in a mild pandemic up to 88% for
a severe pandemic (Figure 3a–3c). The more serious an outbreak
was, the more the predicted uptake depended on effectiveness of a
vaccine, e.g. a vaccine that was 40% less effective compared to the
base case vaccination decreased the vaccination uptake 11, 20 and
28 percent points, for a mild, moderate or severe outbreak
respectively. Irrespective of the disease scenario; higher out-of-
pocket costs had a relatively large impact on the vaccination
uptake, compared to the base case vaccination which was free.
Furthermore, recommendation of the vaccine by physicians, the
government & RIVM or international organizations resulted in a
substantial increase of the predicted uptake of the base case
program (e.g. an increase of 16, 18 and 17 percent points
respectively in case of a mild outbreak). Assuming that all bodies
advised positively regarding the vaccine (including friends and
family) the predicted uptake increased with 32 percent points in
case of a mild outbreak.
Discussion
This DCE showed that effectiveness, safety and out-of-pocket
costs of the vaccine, as well as advice regarding and media
coverage about the vaccine all influenced the general populations’
preference for pandemic vaccinations. Preference heterogeneity
was substantial; two latent classes with different preferences were
identified by a latent class model. Female respondents and
individuals who stated that they would never get vaccinated were
more influenced by the media and more sensitive to costs than
male respondents and individuals who stated that they were
(possibly) willing to get vaccinated. As expected, respondents
Table 4. Willingness to pay.
Attribute To receive a vaccination WTP (J, CI)
Mild pandemic1 Moderate pandemic2 Severe Pandemic3
Effectiveness of vaccine With 10% more effectiveness 6.0 (3.7–8.3) 20 (18–22) 39 (36–44)
Notes: Abbreviations: WTP=willingness to pay; J=euro; CI = 95% confidence interval based on the Krinsky and Robb method adjusted for class probabilities and taking
into account interaction effects (see Figure S3 for more information). (1) Mild pandemic is defined as a disease with a susceptibility of 5% and a severity of 5%. (2)
Moderate pandemic is defined as a disease with a susceptibility of 10% and a severity of 25%. (3) Severe pandemic is defined as a disease with a susceptibility of 20%
and a severity of 75%.
doi:10.1371/journal.pone.0102505.t004
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Figure 3. a. Estimates for predicted probability of participation; values for a mild outbreak. Notes: (1) The percentages represent the
change in probability compared to base case vaccination. (2) The base case vaccination is 70% effective, supposed to be safe, recommended by
friends/family, the traditional media is positive and there are no out-of-pocket costs. This base case is indicated as zero change in the probability of
the x-axis. (3) A mild outbreak is defined as 5% of the population getting sick and 5% of the population getting severe symptoms. (4) Probability of
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preferred and were willing to pay more for more effective vaccines,
especially if the outbreak was more serious. Changes in
effectiveness, out-of-pocket costs of the vaccine and in the body
that advises the vaccine substantially influenced the predicted
uptake.
This is the first DCE investigating how characteristics of
pandemic vaccinations influence preferences for vaccination
programs in different pandemic outbreaks. Two systematic reviews
assessed which factors were associated with uptake of the Influenza
A (H1N1) pandemic vaccine. These also showed the need for
targeted messaging to reach vaccination goals [7,8]. Especially the
conclusion of one of these reviews [7] that social pressure and
confidence in sources of information had an effect on the intention
to vaccinate, is in line with our results. To gain insight in factors
explaining willingness to vaccinate against Influenza A(H1N1) in
The Netherlands, a questionnaire study was conducted among the
general Dutch population during the 2009–2010 pandemic [39].
Similar results as we found were reported: people who were afraid
of the disease, who perceived it as a severe disease, who believed in
the efficacy of the vaccine and who trusted the information the
government provided had higher odds for vaccination. Further-
more, the majority of respondents trusted the information
provided by their general practitioner and more than half of the
respondents trusted the information provided by the Dutch
government and RIVM. Another questionnaire study regarding
the Influenza A(H1N1) pandemic in the Netherlands showed
results that are in line with our results as well; most respondents
wanted to receive information about infection prevention from
municipal health services, health care providers, and the media.
Higher levels of intention to receive vaccination were associated
with increased government trust, fear or worry about the disease,
and perceived vulnerability to the disease [40]. Several DCEs on
non-pandemic vaccines [12,13,41] showed the influence of similar
characteristics on vaccination preferences as we found in our
study. In a DCE on preferences for HPV vaccination [12], it was
found that the degree of protection positively influenced the
preference of girls for vaccination, while the risk of side effects had
a negative effect. A DCE among parents preferences for influenza
vaccination for their children [13], showed that the efficacy of a
vaccination and the recommendation of physicians positively
influenced parents’ preferences, while the risk of temporary side
effects had a negative effect. A DCE on marginal WTP for HIV
vaccines [41] found that biomedical characteristics of a hypothet-
ical HIV vaccine, such as efficacy, vaccine induced seropositivity
and side effects, were the most important attributes for vaccination
programs.
Our results suggest that side effects of the vaccine are less
important than the other included attributes when deciding on
vaccinations, while in other studies (including DCEs) safety of
vaccinations was dominant [7,12,13,41,42]. This difference can
probably be assigned to the choice of attribute levels since
respondents in the current DCE were informed that the chance of
side effects was expected to be low and either comparable to
vaccines that are already on the market or expected to be low, but
with no experience with a similar vaccination yet, i.e. a totally new
vaccination. Our study showed that preference heterogeneity was
substantial. Findings on heterogeneity are supported by a focus
group study on acceptance of hypothetical pandemic vaccinations
in Canada, where parents with non-mainstream beliefs showed
different concerns regarding vaccinations [43].
This study had several limitations. First, we measured prefer-
ences for hypothetical vaccines in hypothetical pandemic out-
breaks. Although we were not able to measure the external validity
of our results, the results may be very helpful in helping to prepare
for pandemic outbreaks. Additionally, the signs of the coefficients
were generally consistent with our a priori hypothesis (a higher
susceptibility to the disease, a higher severity of the disease and a
higher effectiveness would have a positive effect on vaccination)
and therefore, theoretically valid. Second, the participation rate of
49% was not optimal and selection bias cannot be excluded.
However, this participation rate is equal or even higher than most
other DCEs in health care. Furthermore, the participation rate
was comparable to the average rate of the internet panel we used.
We expect our results to be generalizable since age, gender, level
of education and region of our sample are comparable to that of
the general population of the Netherlands. Third, due to both the
number and the type of attributes and levels that respondents
needed to take into account when completing the choice tasks, it
can be expected that respondents might have experienced
difficulties, which might have influenced the results. However,
piloting and think-a-loud interviews in the preparation phase, as
well as questions that assessed the experienced difficulty of the
questionnaire showed that the majority of respondents had no
problems with completing the tasks. Fourth, we included safety of
the vaccine as a categorical attribute, instead of a numerical
attribute, which would have helped respondents to compare risks
of vaccinations with risks of the disease. However, when designing
the DCE, expert interviews showed that safety of the vaccine is
more or less a fixed attribute (either being sure that the vaccine will
be safe, or that there is no experience with the vaccine yet and
there is thus a chance of long-term side effects). Therefore, we
included the safety of the vaccine as an attribute with categorical
levels.
Insights in the factors influencing the intention to accept or
decline a pandemic vaccine may have implications for both
national and international policy and for further research. When
communicating public health messages regarding vaccination, one
should be aware of preference heterogeneity and therefore use
different sources and channels to distribute the messages [44]. The
current study provides guidance on how to target public health
messages, by the identification of two classes with different
preferences for pandemic vaccinations. To immediately reduce
the number of susceptible people, a possible strategy could be to
target the message for the first phase of a vaccination program to
the more vaccination minded persons, here latent class 1. This can
be done by using the government and RIVM as bodies to advice
the vaccine to males and focus more on the expected effectiveness
of the vaccine. Next, physicians can advise females to take the
base case vaccination in this scenario = 50%. b. Estimates for predicted probability of participation; values for a moderate outbreak.
Notes: (1) The percentages represent the change in probability compared to base case vaccination. (2) The base case vaccination is 70% effective,
supposed to be safe, recommended by friends/family, the traditional media is positive and there are no out-of-pocket costs. This base case is
indicated as zero change in the probability of the x-axis. (3) A moderate outbreak is defined as 10% of the population getting sick and 25% of the
population getting severe symptoms. (4) Probability of base case vaccination in this scenario = 65%. c. Estimates for predicted probability of
participation; values for a severe outbreak. Notes: (1) The percentages represent the change in probability compared to base case vaccination.
(2) The base case vaccination is 70% effective, supposed to be safe, recommended by friends/family, the traditional media is positive and there are no
out-of-pocket costs. This base case is indicated as zero change in the probability of the x-axis. (3) A severe outbreak is defined as 20% of the
population getting sick and 75% of the population getting severe symptoms. (4) Probability of base case vaccination in this scenario = 88%.
doi:10.1371/journal.pone.0102505.g003
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vaccine. Additionally, out-of-pocket costs need to be as low as
possible, as our study showed the negative relation between out-of-
pocket costs and vaccination decisions. For public health messages
during vaccination programs, it is also important to monitor side
effects. Updates of the side effects of the vaccine need to be given
on a regularly basis to make sure that an informed choice can be
made and to reduce fear of the side effects of the vaccine.
Furthermore, policy makers can use the expected uptake
probability of hypothetical vaccinations when predicting the
number of vaccinations that is needed. Although these numbers
are rough estimates and it is not known if they are externally valid,
the expected uptake can still be useful when other information is
lacking. Additionally, these numbers can guide communication on
the expected vaccination uptake. Since this is the first quantitative
study in motivations for pandemic vaccinations, we do not know to
what extent differences exist between countries regarding prefer-
ences for vaccinations. There is some evidence, including a
questionnaire study in four countries investigating reasons why
high risk people reject influenza vaccination in four countries of
Europe suggests differences between respondents of the different
countries [45]. Therefore, further international research is
recommended.
We conclude that various disease and vaccination program
attributes influence respondents’ preferences for pandemic vacci-
nation programs. Agencies responsible for preventive measures
during pandemics can use the findings of this study that out-of-
pocket costs and the way advice is given affect vaccination uptake
to change the way vaccination is marketed during future pandemic
outbreaks. The preference heterogeneity shows that information
regarding vaccination needs to be targeted differently depending
on gender and willingness to get vaccinated.
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